Clinicians & Patient Groups Requesting AveXis Clarification About Potential Limited Global Access to Zolgensma

19 December 2019 / Posted in: Treatments & Research

We're aware that complex and sensitive information regarding potential but very limited global access to the gene therapy treatment Zolgensma has been shared online. Clinicians and patient groups have expressed their concerns to the drug company AveXis requesting, as a matter of urgency, public clarification of the position.

Read full story

New SMA Voices: Gary Shares His Experiences

18 December 2019 / Posted in: Information, Support

In this video, Gary looks back at his childhood and forward to present day, and shares his experiences of what it’s like to live with Spinal Muscular Atrophy.

Read full story

Information and Support over the Christmas Break

11 December 2019 / Posted in: Information, Support

Our office is closed from 1pm on Friday 20th December 2019. We re-open on Thursday 2nd January 2020 at 9.00am. Here are links to where you can access support and information about SMA during this time.

Read full story

Together for Short Lives Launches Youth-Led Creative Artwork Project

10 December 2019 / Posted in: Information, Support

Called 'This Is Me', the project provides an opportunity for young people with life-limiting conditions in the UK to express themselves through the creative arts. Submissions deadline is 20th January 2020.

Read full story

Support the #NeuroPledge2019

03 December 2019 / Posted in: Information, Support

The Neurological Alliance are asking parliamentary candidates to take the #NeuroPledge2019. It commits them to campaigning for improvements for people with neurological conditions, if they become an MP. Find out how you can get involved and write to your prospective MP.

Read full story

Nusinersen Managed Access Agreement – Update on Progress with Services for Adults

02 December 2019 / Posted in: Treatments & Research

NHS England has let the Patient Advocacy Groups (PAGs) know which hospitals now have contracts to offer adults treatment, and their plans to address any service gaps.

Read full story

CONCORD Survey about the Coordination of Care for Rare Conditions

28 November 2019 / Posted in: Information, Support

The COordiNated Care Of Rare Diseases (CONCORD) research study is currently looking for patients, carers and healthcare professionals to share their priorities and views about the coordination of care for rare conditions, via their online survey. Survey closes Sunday 8th December.

Read full story

FDA Grants Priority Review to Risdiplam for the Treatment of SMA

25 November 2019 / Posted in: Treatments & Research

The FDA’s decision will be announced on 24th May 2020. If approved, risdiplam, an orally administered liquid, would be the first at-home administered medicine for people living with SMA.

Read full story

Scholar Rock Reports Preliminary Pharmacokinetic and Pharmacodynamic Data from TOPAZ Phase 2 Trial of SRK-015 for the Treatment of SMA

25 November 2019 / Posted in: Treatments & Research

SRK-015 is an experimental therapy directed at the muscle, that aims to reverse or restrict the atrophy and weakness experienced by SMA patients.

Read full story

SMA UK’s Trust Board makes Research Strategy and Funding decisions

21 November 2019 / Posted in: Treatments & Research

We are pleased to announce our SMA PhD Partnership with MDUK that is open for applications now along with our pledge to support SMA Europe’s research call. For more details and information about this and other 2019/20 grants, please click here.

Read full story